Is Vir Biotechnology, Inc. (VIR) a Buy, Sell, or Hold?
Vir Biotechnology, Inc.
NASDAQ:VIR
$9.49 USD
-$0.23 (-2.37%)
- Volume
- 1.68M
- Average Volume
- 1.89M
- Market Capitalization
- $1.6B
- P/E Ratio
- -3.03
- Dividend Yield
- 0.00%
- Price Target
- $20.00
- Year High
- $11.66
- Year Low
- $4.16
- Day High
- —
- Day Low
- —
- Payout Ratio
- $0.00
- Current Ratio
- $7.11
Analyst Rating
Sell
2 Rating Score
UPSIDE/DOWNSIDE
-52.6% DOWNSIDE
$20.00 Price Target
UPSIDE/DOWNSIDE HIGH
-68.4% DOWNSIDE
$30.00 Price Target High
UPSIDE/DOWNSIDE LOW
-47.3% DOWNSIDE
$18.00 Price Target Low
INSIDER TRADING
Shares
$- Last Quarter
| Analyst Company | Analyst Name | Price Target | Price When Posted | Date | Upside/Downside |
|---|---|---|---|---|---|
| H.C. Wainwright | Patrick Trucchio | $20 | $9.13 | 2026-03-04 06:41 AM | 119.1% |
| Leerink Partners | Roanna Ruiz | $20 | $9.325 | 2026-02-26 01:07 PM | 114.5% |
| Evercore ISI | Cory Kasimov | $18 | $9.7 | 2026-02-24 08:02 AM | 85.6% |
| Needham | Joseph Stringer | $18 | $9.64 | 2026-02-24 07:05 AM | 86.7% |
| Morgan Stanley | Michael Ulz | $24 | $7.43 | 2026-02-24 06:49 AM | 223.0% |
| Raymond James | Sean McCutcheon | $19 | $9.69 | 2026-02-24 06:05 AM | 96.1% |